Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s “Revision” indicator was updated from v3.5.2 to v3.5.3, reflecting a site/version change rather than an update to the clinical trial record.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.5.0 has been added. Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.4.3 is shown, replacing the previous v3.4.2. No study data or actionable details are altered.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded Revision: v3.4.2; removed the government-funding downtime notice and the previous Revision: v3.4.1.SummaryDifference0.5%

- Check97 days agoChange DetectedA site-wide notice regarding potential updates due to funding and a new revision stamp (Revision: v3.4.1) were added, replacing the previous v3.4.0. These changes do not affect study data, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.